Dr. Elena Stoffel, MD
Claim this profileUniversity of Michigan Comprehensive Cancer Center
Studies Colorectal Cancer
Studies Adenomatous Polyposis
6 reported clinical trials
12 drugs studied
Area of expertise
1Colorectal Cancer
Stage III
Stage II
MSH2 positive
2Adenomatous Polyposis
Stage III
Stage II
APC positive
Affiliated Hospitals
Clinical Trials Elena Stoffel, MD is currently running
Obeticholic Acid
for Familial Adenomatous Polyposis
This phase IIa trial investigates if giving obeticholic acid (OCA) is safe and has a beneficial effect on the number of polyps in the small bowel and colon in patients with familial adenomatous polyposis (FAP). FAP is a rare gene defect that increases the risk of developing cancer of the intestines and colon. OCA is a drug similar to a bile acid the body makes. It is fluid made and released by the liver. OCA binds to a receptor in the intestine that is believed to have a positive effect on preventing cancer development. OCA has been effective in treating primary biliary cholangitis (PBC), a liver disease, and is approved by the Food and Drug Administration (FDA) for use at a lower dose (10 mg). There have been studies showing that OCA decreases inflammation and fibrosis. However, it is not yet known whether OCA works on reducing the number of polyps in patients with FAP.
Recruiting0 awards Phase 2
Cancer Vaccines
for Lynch Syndrome
This trial tests a vaccine and an immune booster to prevent cancer in people with Lynch syndrome. The vaccine teaches the body to fight cancer, and the booster makes this process stronger. Vaccines have shown robust potential for preventing Lynch syndrome cancers.
Recruiting0 awards Phase 214 criteria
More about Elena Stoffel, MD
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Elena Stoffel, MD has experience with
- Obeticholic Acid
- Motivational Interviewing (MI)
- Virtual Genetics Navigator
- Placebo
- Adenovirus 5 CEA/MUC1/Brachyury Vaccine Tri-Ad5
- Nogapendekin Alfa
Breakdown of trials Elena Stoffel, MD has run
Colorectal Cancer
Adenomatous Polyposis
Pancreatic Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elena Stoffel, MD specialize in?
Elena Stoffel, MD focuses on Colorectal Cancer and Adenomatous Polyposis. In particular, much of their work with Colorectal Cancer has involved Stage III patients, or patients who are Stage II.
Is Elena Stoffel, MD currently recruiting for clinical trials?
Yes, Elena Stoffel, MD is currently recruiting for 3 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Elena Stoffel, MD has studied deeply?
Yes, Elena Stoffel, MD has studied treatments such as Obeticholic Acid, Motivational interviewing (MI), Virtual genetics navigator.
What is the best way to schedule an appointment with Elena Stoffel, MD?
Apply for one of the trials that Elena Stoffel, MD is conducting.
What is the office address of Elena Stoffel, MD?
The office of Elena Stoffel, MD is located at: University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109 United States. This is the address for their practice at the University of Michigan Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.